The round was led by Pioneer Fund, Icehouse Ventures and BreakTHRU, a syndicate of animal-health industry leaders and veterinarians, with participation from angel investors.

Familiar Therapeutics is a biotechnology company bringing medicines first developed for people to dogs and cats. The company licenses veterinary rights to drugs with years of human research behind them, then leads the veterinary development and regulatory work needed to bring them to pets, with the goal of advancing selected programs significantly faster than typical animal drug development.